UK markets closed

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.71+0.60 (+5.40%)
At close: 04:00PM EDT
11.71 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-292,191
-292,191
-236,806
-158,725
-117,841
Depreciation & amortisation
1,389
1,389
1,426
544
160
Deferred income taxes
-853
-853
-769
-2,510
17
Stock-based compensation
54,822
54,822
46,840
35,737
23,146
Change in working capital
5,864
5,864
13,252
16,605
7,844
Accounts receivable
-
-
-
413
-277
Accounts payable
10,919
10,919
15,527
13,964
14,307
Other working capital
-208,405
-208,405
-166,299
-160,200
-87,583
Other non-cash items
15,045
15,045
-
-
-
Net cash provided by operating activities
-207,822
-207,822
-163,751
-154,093
-86,825
Cash flows from investing activities
Investments in property, plant and equipment
-583
-583
-2,548
-6,107
-758
Acquisitions, net
0
0
0
-14,320
0
Purchases of investments
-549,182
-549,182
-533,161
-363,508
-400,984
Sales/maturities of investments
505,307
505,307
421,529
365,820
116,910
Net cash used for investing activities
-44,458
-44,458
-114,180
-18,115
-284,832
Cash flows from financing activities
Common stock issued
237,303
237,303
261,043
179,667
327,787
Other financing activities
-
-
-
-1,146
18,424
Net cash used provided by (used for) financing activities
237,303
237,303
261,043
178,521
360,439
Net change in cash
-14,977
-14,977
-16,888
6,313
-11,218
Cash at beginning of period
45,696
45,696
62,584
56,271
67,489
Cash at end of period
30,719
30,719
45,696
62,584
56,271
Free cash flow
Operating cash flow
-207,822
-207,822
-163,751
-154,093
-86,825
Capital expenditure
-583
-583
-2,548
-6,107
-758
Free cash flow
-208,405
-208,405
-166,299
-160,200
-87,583